* Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type (346 visite)
Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2008 Aug 15; 14(16): 5209-5219.
Impact Factor: 6.488
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging Of Lung Cancer Resistance To Egfr Tyrosine Kinase Inhibitors Trough Bcl-2/Bcl-Xl Modulation Of Inositol Trisphosphate Receptor Type (249 visite)
Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Eur J Nucl Med, 2008; suppl2: N/D-N/D.
Impact Factor: 5.563
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of lung cancer resistance to EGFR tyrosine kinase inhibitors through Bcl-2/Bcl-x(L) modulation of inositol trisphosphate receptor type (253 visite)
Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of Bcl-2/Bcl-x(L) dysregulated apoptotic program in NSCLC cells resistant to EGFR tyrosine kinase inhibitors (263 visite)
Zannetti A, Iommelli F, Fonti R, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

* SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer (276 visite)
Zannetti A, Fonti R, Iommelli F, Papaccioli A, Sommella J, Tortora G, Bianco R, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: 277-309.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Gefitinib, A Selective, Tyrosine Kinase Inhibitor Increases 99mtc-Mibi Uptake In Bcl-2 Overexpressing Breast Cancer Cells (273 visite)
Zannetti A, Del Vecchio S, Fonti R, Iommelli F, Sommella J, Potena A, Salvatore M
Mol Immunol, 2005; 4: 355-355.
Impact Factor: 3.003
Dettagli    Esporta in BibTeX    Esporta in EndNote

Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma (322 visite)
Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 2000 Mar 15; 60(6): 1546-1551.
Impact Factor: 8.46
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Towards a knowledge ecosystem (179 visite)
Slavazza P, Fonti R, Ferraro M, Biasuzzi C, Gilardoni L
Lecture Notes In Computer Science (ISSN: 0302-974335404636319783540463634, 0302-974335402975459783540297543), 2006; 4248LNAI: 366-380.
Impact Factor: 0.302
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging Integrato Del Mieloma Multiplo Con 18fdg-Pet/Tc, Tc99m-Mibi E Rm (236 visite)
Sirignano C, Fonti R, Soscia E, Iodice D, Del Vecchio S, Salvatore M
La Radiologia Medica, 2008; 113: ISSN-1826.
Impact Factor: 1.368
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Evaluation of metabolic response with (18)F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors (149 visite)
Segreto S, Fonti R, Ottaviano M, Pellegrino S, Pace L, Damiano V, Palmieri G, Del Vecchio S
Cancer Imaging (ISSN: 1470-7330, 1470-7330electronic), 2017 Mar 7; 17(1): 10-10.
Impact Factor: 3.016
Dettagli    Esporta in BibTeX    Esporta in EndNote

* New frontiers of nuclear medicine (314 visite)
Salvatore M, Fonti R
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2002 May; 88(3): S60-S60.
Impact Factor: 0.267
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FDG PET/CT in the assessment of early response to chemotherapy and molecularly targeted agents in metastatic colorectal cancer (164 visite)
Salvatore B, Simeone R, Fonti R, Marciano R, Bianco R, Damiano V, Tortora G, Pace L, Del Vecchio S, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy (295 visite) (PDF 117 visite)
Salvatore B, Klain M, Nicolai E, D'Amico D, De Matteis G, Raddi M, Fonti R, Pellegrino T, Storto G, Cuocolo A, Pace L
Medicine (ISSN: 0025-7974), 2017 Oct; 96(42): e8344-e8344.
Impact Factor: 2.028
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis (97 visite)
Salvatore B, Fonti R, De Renzo A, Pellegrino S, Ferrara IL, Mainolfi CG, Marano L, Selleri C, Pane F, Del Vecchio S, Pace L
Q J Nucl Med Mol Im (ISSN: 1827-1936electronic, 1824-4785linking), 2018 Apr 24; N/D: N/D-N/D.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT (137 visite)
Salvatore B, D'Amico D, Fonti R
Clin Nucl Med (ISSN: 1536-0229electronic, 0363-9762linking), 2018 May; 43(5): 363-364.
Impact Factor: 0.253
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Is 2-deoxy-2-[(18)F]fluoro-D-glucose PET/CT acquisition from the upper thigh to the vertex of skull useful in oncological patients? (145 visite)
Salvatore B, Caprio MG, Fonti R, D'Amico D, Fraioli F, Salvatore M, Pace L
Transl Med Unisa (ISSN: 2239-9747, 2239-9747electronic, 2239-9747linking), 2015 Jan; 11(6): 34-38.
Impact Factor: 2.256
Dettagli    Esporta in BibTeX    Esporta in EndNote

Chirurgia Oncologica Radioimmunoguidata: Possibilità Di Incremento Qualitativo Del Metodo (161 visite)
Renda A, Iovino F, Capasso L, Scola R, Ricciardelli L, Fonti R
Archivio Ed Atti Della Società Italiana Di Chirurgia, 1998; 3: 425-442.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation? (167 visite)
Perrella O, Liguori G, Cattaneo D, Morelli L, Precchia E, Morisco E, Fonti R, Marinelli P
G Mal Infett Parassit (ISSN: 0017-0321), 1992; 44(1): 65-68.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation? [LIVELLI DI IG AD ISOTIPO DIVERSO E QUADRO ISTOLOGICO NELLA PATOLOGIA GASTRICA ASSOCIATA ALL'HELICOBACTER PYLORI: QUALE CORRELAZIONE?] (238 visite)
Perrella O, Liguori G, Cattaneo D, Morelli L, Precchia E, Morisco E, Fonti R, Marinelli P
G Mal Infett Parassit (ISSN: 0017-0321), 1992; 44: 65-68.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer (16 visite)
Pellegrino S, Fonti R, Mazziotti E, Piccin L, Mozzillo E, Damiano V, Matano E, De Placido S, Del Vecchio S
Ann Nucl Med (ISSN: 0914-7187linking), 2019 Dec; 33(12): 937-944.
Impact Factor: 1.41
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Evidence of brown fat activity in constitutional leanness (317 visite)
Pasanisi F, Pace L, Fonti R, Marra M, Sgambati D, De Caprio C, De Filippo E, Vaccaro A, Salvatore M, Contaldo F
J Clin Endocrinol Metab (ISSN: 1945-7197, 0021-972x, 0021-972xlinking), 2013 Mar; 98(3): 1214-1218.
Impact Factor: 6.31
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Combined 18F-FDG-PET/CT and 111In-Octreotide SPECT for Evaluation of Thymic Epithelial Tumors (185 visite)
Palmieri G, Fonti R, Federico P, Del Prete G, Pacelli R, Pace L, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Impact Factor: 5.114
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Prognostic Role of 18F-FDG PET/CT in the Postoperative Evaluation of Differentiated Thyroid Cancer Patients (256 visite)
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Prognostic Role Of 18f-Fluorodeoxyglucose Positron Emission Tomography/Ct In The Postoperative Evaluation Of Differentiated Thyroid Cancer Patients (171 visite)
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Wash-out of 99mTc-sestamibi (99mTc-MIBI) in evaluating response to chemotherapy in patients with multiple myeloma (MM) (206 visite)
Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Sica G, Annunziata G, Califano C, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma (216 visite)
Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Salvatore B, Andretta C, Di Nuzzo C, Rotoli B, Salvatore M
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2005 Sep; 49(3): 281-285.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Changes of glycolytic pathway and upregulation of oxidative phosphorylation in BCR-ABL-driven human leukemia cells treated with imatinib (236 visite)
Monti M, De Rosa V, Iommelli F, Fonti R, Pane F, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015 Oct; 42: N/D-N/D.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins (146 visite)
Monti M, De Rosa V, Iommelli F, Carriero MV, Terlizzi C, Camerlingo R, Belli S, Fonti R, Di Minno G, Del Vecchio S
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2018 Aug 9; 19(8): N/D-N/D.
Impact Factor: 3.687
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Tumor Detection in Syndromic NET: Zollinger-Ellison Syndrome (139 visite)
Modica R, Camera L, NapolitanoV, Avellino M, Fonti R, Del Vecchio S, De LucaL, Colao A, Faggiano A
Neuroendocrine Tumors In Real Lif, 2018; e: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (289 visite)
Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
Dettagli    Esporta in BibTeX    Esporta in EndNote

Transient expression of glial-fibrillary acidic protein (GFAP) in the ependyma of the regenerating spinal cord in adult newts (285 visite)
Margotta V, Fonti R, Palladini G, Filoni S, Lauro GM
Journal Fur Hirnforschung (ISSN: 0021-8359), 1991; 32(4): 485-490.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (314 visite)
Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (188 visite)
Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
Dettagli    Esporta in BibTeX    Esporta in EndNote

Phylogenetic evolution of intermediate filament associated proteins in ependymal cells of several adult poikilotherm vertebrates (302 visite)
Lauro GM, Fonti R, Margotta V
Journal Fur Hirnforschung (ISSN: 0021-8359), 1991; 32(2): 257-261.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Characterization of the mucins produced by normal human colonocytes in primary culture (178 visite)
Latella G, Fonti R, Caprilli R, Marcheggiano A, Magliocca F, Das KM, Gambús G, Sambuy Y
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 1996; 11(2): 76-83.
Impact Factor: 0.732
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1) (166 visite)
Lastoria S, Marciello F, Faggiano A, Aloj L, Caraco C, Aurilio M, D'Ambrosio L, Di Gennaro F, Ramundo V, Camera L, De LucaL, Fonti R, Napolitano V, Colao A
Endocrine (ISSN: 1355-008x), 2016 Jun; 52(3): 488-494.
Impact Factor: 3.131
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18-FDG PET/CT texture analysis in patients with head and neck cancer (144 visite)
Larobina M, Salvatore B, Fonti R, Solla R, Murino L, Del Vecchio S, Pace L
European Journal Of Nuclear Medicine And Molecular Imaging, 2018; 45(Suppl1): PW043-PW043.
Impact Factor: 7.2
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Radiomics analysis of 18F-FDG PET/CT images: preliminary results in patients with head and neck cancer (137 visite)
Larobina M, Murino L, Solla R, Fonti R, Salvatore B, Del Vecchio S, Mansi L, Pace L
Clinical And Translational Imaging, 2019; Vol.7-Suppl.1: PO058-PO058.
Impact Factor: 0.656
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by (18)F-fluorothymidine (528 visite)
Iommelli F, De Rosa V, Terlizzi C, Monti M, Panico M, Fonti R, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432print, 1078-0432linking), 2018 Jul 1; 24(13): 3126-3136.
Impact Factor: 10.199
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Preclinical Imaging in Targeted Cancer Therapies (110 visite)
Iommelli F, De Rosa V, Terlizzi C, Fonti R, Del Vecchio S
Semin Nucl Med (ISSN: 0001-2998linking), 2019 Sep; 49(5): 369-381.
Impact Factor: 3.798
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FLT PET/CTas a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC (226 visite)
Iommelli F, De Rosa V, Monti M, Panico M, Fonti R, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015 Oct; 42: N/D-N/D.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FLT PET/CT for Detection of Functional Cross-talk between MET and EGFR in Non-small Cell Lung Cancer Resistant to EGFR Inhibitors (254 visite)
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Ortosecco G, Greco A, Gramanzini M, Fonti R, Brunetti A, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Using 3 '-Deoxy-3 '-[F-18]-Fluorothymidine Positron Emission Tomography (352 visite)
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Greco A, Gramanzini M, Ortosecco G, Fonti R, Brunetti A, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2014 Sep 15; 20(18): 4806-4815.
Impact Factor: 8.722
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Monitoring Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by 18F-FLT PET/CT (216 visite)
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Gramanzini M, Fonti R, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2014 Oct; 41: N/D-N/D.
Impact Factor: 5.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular Imaging For Detection Of Sensitivity And Resistance To Egfr Tyrosine Kinase Inhibitors In Non-Small Cell Lung Cancer (185 visite)
Iommelli F, De Rosa V, Fonti R, Del Vecchio S
Clin Transl Imaging (ISSN: 2281-5872print, 2281-7565online), 2014 Feb 20; 2(1): 43-53.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lymph node mapping and sentinel lymph node biopsy for evaluation of axillary lymph node status in early invasive breast cancer. Our experience (248 visite)
Formisano C, Limite G, Lamberti M, Fonti R, Forestieri P
Przegl Lek (ISSN: 0033-2240print, 0033-2240linking), 2000; 57Suppl5: 113-115.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Evidence Of Brown Adipose Tissue Astivity Assessed By 18f-Fdg-Pet/Ct In Females With Constitutional Leanness (175 visite)
Fonti R, Sgambati D, Vaccaro A, Pasanisi F, De Caprio C, Salvatore M, Pace L, Contaldo F
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012; 39: S401-S401.
Impact Factor: 5.114
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Evidence of Brown Adipose Tissue Activity Assessed by 18F-FDG-PET/CT in Females with Constitutional Leanness (164 visite)
Fonti R, Sgambati D, Vaccaro A, Pasanisi F, De Caprio C, Pace L, Contaldo F, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Impact Factor: 5.114
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma (208 visite)
Fonti R, Salvatore B, Ricci F, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: N/D-N/D.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma (164 visite)
Fonti R, Salvatore B, Ricci F, Petruzziello F, Catalano L, Del Vecchio S, Pace L, Salvatore M, Rotoli B
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 2007 Oct; 92: N/D-N/D.
Impact Factor: 5.516
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18-FDG-PET/CT, 99mTC-MIBI and MRI in the evaluation of patients with multiple myeloma (244 visite)
Fonti R, Salvatore B, Ricci F, Petruzziello F, Catalano L, Del Vecchio S, Pace L, Salvatore M, Rotoli B
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 2007 Oct; 92: N/D-N/D.
Impact Factor: 5.516
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18-FDG PET/CT, Tc-99m-MIBI, and MRI in evaluation of patients with multiple myeloma (349 visite)
Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M
J Nucl Med (ISSN: 0161-5505, 0161-1550, 1535-5667), 2008 Feb; 49(2): 195-200.
Impact Factor: 6.662
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FDG-PET/CT, 99mTc-MIBI and MRI in the evaluation of patients with multiple myeloma (294 visite)
Fonti R, Salvatore B, Quarantelli M, Sirignano C, Cammarano F, Segreto S, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Multimodality Imaging With 18f-Fdg-Pet/Ct, 99mtc-Mibi And Mri Of Multiple Myeloma (225 visite)
Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M
Proceedings Of The 2nd International Conference Of The European Society For Molecular Imaging Naples Italy, 2007; N/D: 56-56.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18f-Fdg-Pet/Ct, 99mtc-Mibi And Mri Inpatients With Multiple Myeloma (244 visite)
Fonti R, Salvatore B, Quarantelli M, Sirignano C, Cammarano F, Segreto S, Petruzziello F, Catalano L, Martinelli V, Rotoli B, Del Vecchio S, Pace L, Salvatore M
Multimodality Imaging With Proceedings Of The Ix Congress Of The Italian Society Of Experimental Hematology, 2006; PO164: 53-53.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma (210 visite)
Fonti R, Salvatore B, De Renzo A, Nicolai E, Del Vecchio S
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2016 Feb; 41(2): 169-172.
Impact Factor: 4.563
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma (46 visite)
Fonti R, Pellegrino S, Catalano L, Pane F, Del Vecchio S, Pace L
Ann Hematol (ISSN: 0939-5555linking), 2020 Jan; 99(1): 127-135.
Impact Factor: 2.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study (310 visite) (PDF 197 visite)
Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, Pane F, Salvatore M, Del Vecchio S
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Apr; 40(4): 303-308.
Impact Factor: 4.278
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FDG-PET/CT, 99mTc-MIBI and MRI in the Prediction of Outcome of Patients with Multiple Myeloma (215 visite)
Fonti R, Pace L, Cerchione C, Catalano L, Pane F, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015 Jan 20; 40: 303-308.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FDG-PET/CT and 111In-Octreotide SPECT in Patients with Metastatic Medullary Thyroid Carcinoma (178 visite)
Fonti R, Mainolfi C, Anzivino A, Camera L, Faggiano A, Colao A, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Sentinel lymph node identification in breast cancer patients (232 visite)
Fonti R, Limite G, Sodano A, Riccardi A, Forestieri P, De Cristofaro G, Pettinato G, Salvatore M
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2002 Apr; 103(4): 370-377.
Impact Factor: 1.368
Dettagli    Esporta in BibTeX    Esporta in EndNote

Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography (180 visite)
Fonti R, Levchenko A, Mehta BM, Zhang J, Tsuruo T, Larson SM
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999 Jan; 26(1): 35-41.
Impact Factor: 1.623
Dettagli    Esporta in BibTeX    Esporta in EndNote

Carbonic anhydrase I reduction in colonic mucosa of patients with active ulcerative colitis (179 visite)
Fonti R, Latella G, Caprilli R, Frieri G, Marcheggiano A, Sambuy Y
Digestive Diseases And Sciences (ISSN: 0163-2116), 1998; 43(9): 2086-2092.
Impact Factor: 1.972
Dettagli    Esporta in BibTeX    Esporta in EndNote

Human colonocytes in primary culture: a model to study epithelial growth, metabolism and differentiation (292 visite)
Fonti R, Latella G, Bises G, Magliocca F, Nobili F, Caprilli R, Sambuy Y
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 1994; 9(1): 13-22.
Impact Factor: 0.732
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Metabolic Tumor Volume assessed by 18F-FDG-PET/CT in the evaluation of plasma cell mass and prediction of outcome in patients with multiple myeloma (210 visite)
Fonti R, Larobina M, Fabbricini R, Catalano L, Pace L, Del Vecchio S, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma (310 visite)
Fonti R, Larobina M, Del Vecchio S, Fabbricini R, Catalano L, Pane F, Salvatore M, Pace L
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Dec; 53(12): 1829-1835.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma (266 visite)
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.
Impact Factor: 3.239
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma (291 visite)
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001; 28(2): 214-220.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (355 visite)
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
Dettagli    Esporta in BibTeX    Esporta in EndNote

Technetium-99m-Monoclonal Antibody Radio-Labeled Via Hydrazino Nicotinamide Derivative For Imaging Ganglioside Gd2-Positive Tumors (156 visite)
Fonti R, Cheung NKV, Bridger GJ, Shen SQ, Finn RD, Abrams RJ, Larson SM
Nucl Med Biol, 1999; 26: 681-686.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (223 visite)
Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
Dettagli    Esporta in BibTeX    Esporta in EndNote

* The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study (121 visite)
Faggiano A, Modica R, Severino R, Camera L, Fonti R, Del Prete M, Chiofalo MG, Aria M, Ferolla P, Vitale G, Pezzullo L, Colao A
Endocrine (ISSN: 1355-008xlinking), 2018 Oct; 62(1): 46-56.
Impact Factor: 3.179
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw (177 visite)
Fabbricini R, Catalano L, Pace L, Del Vecchio S, Fonti R, Salvatore M, Rotoli B
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2009 Aug; 50(8): 1385-1385.
Impact Factor: 6.424
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Functional imaging of multidrug resistance in breast cancer (276 visite)
Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Salvatore M
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2006; 21(SUPPL.1): 24-27.
Impact Factor: 0.313
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake in Bcl-2 overexpressing non-Hodgkin's lymphoma patients during drug-induced apoptosis (234 visite)
Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Iommelli F, De Renzo A, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.
Impact Factor: 3.935
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Stato Dell’arte Dell’imaging Preclinico In Oncologia (256 visite)
Del Vecchio S, Zannetti A, Iommelli F, Fonti R, Speranza A
Q J Nucl Med Mol Im (ISSN: 1827-1936, 1827-1936electronic, 1824-4785linking), 2011; 55: 20-21.
Impact Factor: 2.256
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Nuclear imaging in cancer theranostics (436 visite)
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells during treatment with gefitinib, a selective tyrosine kinase inhibitor (252 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Sommella I, Potena A, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.
Impact Factor: 3.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Tc-99m-MIBI in the evaluation of breast cancer biology (417 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Salvatore M
Breast Cancer (ISSN: 9783-540367802), 2004 Jun; 1: 71-81.
Impact Factor: 0.635
Dettagli    Esporta in BibTeX    Esporta in EndNote

* PET/CT in cancer research: From preclinical to clinical applications (443 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Pizzuti LM, Lettieri A, Salvatore M
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2010 Jul; 5(4): 190-200.
Impact Factor: 4.02
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular imaging of drug resistance in cancer (302 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Lettieri A, Salvatore M
Minerva Biotecnol (ISSN: 1120-4826), 2009 Mar; 21(1): 31-36.
Impact Factor: 0.268
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake and Bcl-2 overexpression in untreated breast cancer patients (245 visite)
Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Fonti R, Caraco C, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Dynamic coupling of Tc-99m-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients (311 visite)
Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 0340-6997, 1619-7089), 2002 Jun; 29(6): 809-814.
Impact Factor: 3.568
Dettagli    Esporta in BibTeX    Esporta in EndNote

Urokinase and urokinase receptor overexpression in breast carcinoma as compared to benign lesions (141 visite)
Del Vecchio S, Stoppelli P, Fonti R, Carriero MV, Li P, Salvatore M
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 1993; 34(0): N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

IN-VITRO RECEPTOR IMAGING FOR CHARACTERIZATION OF HUMAN SOLID TUMORS (172 visite)
Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1994 Jul; 21(5): 771-774.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels (172 visite)
Del Vecchio S, Stoppelli MP, Carriere MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1993 Jul 1; 53(13): 3198-3206.
Impact Factor: 8.426
Dettagli    Esporta in BibTeX    Esporta in EndNote

Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma (249 visite)
Del Vecchio S, Fonti R, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.
Impact Factor: 3.239
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Capitolo VII: Oncologia (200 visite)
Del Vecchio S, Fonti R, Picchio M, Mapelli P, Gianolli L, Messa C
Medicina Nucleare Metodologie Ed Applicazioni Diagnostiche, 2010; N/D: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Efflux rate of Tc-99m-MIBI and apoptosis in untreated breast cancer patients (235 visite)
Del Vecchio S, Ciarmiello A, Zannetti A, Fonti R, Botti G, D'Aiuto G, Salvatore M
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2000 May; 41(5): N/D-N/D.
Impact Factor: 3.617
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells (205 visite)
De Rosa V, Monti M, Terlizzi C, Fonti R, Del Vecchio S, Iommelli F
Int J Mol Sc (ISSN: 1422-0067linking, 1661-6596, 1422-0067electronic), 2019 Jun 27; 20(13): N/D-N/D.
Impact Factor: 4.183
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Changes of Glycolytic Pathway in Response to Efficient Inhibition of EGFR Signaling in Non-small Cell Lung Cancer (NSCLC) (186 visite)
De Rosa V, Iommelli F, Votta G, Monti M, Ortosecco G, Fonti R, Mainolfi C, Stoppelli M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors (213 visite)
De Rosa V, Iommelli F, Monti M, Mainolfi CG, Fonti R, Del Vecchio S
Ejnmmi Res, 2016 Dec; 6(1): 74-74.
Impact Factor: 1.761
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC (271 visite)
De Rosa V, Iommelli F, Monti M, Mainolfi C, Fonti R, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015 Oct; 42: N/D-N/D.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer (490 visite)
De Rosa V, Iommelli F, Monti M, Fonti R, Votta G, Stoppelli MP, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2015 Nov 15; 21(22): 5110-5120.
Impact Factor: 8.738
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Early reduction of 18F-FDG uptake in non-small lung cancer treated with EGFR tyrosine kinase inhibitors reflects reversal of Warburg effect and reactivation of oxidative phosphorylation (173 visite)
De Rosa V, Iommelli F, Monti M, Fonti R, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2014 Oct; 41: N/D-N/D.
Impact Factor: 5.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma (232 visite)
De Luca  S, Fonti R, Camera L, Salvatore B, Faggiano A, Ciarmiello A, Segreto S, Colao A, Salvatore M, Del Vecchio S
Ann Nucl Med (ISSN: 0914-7187, 1864-6433), 2016 Jan 11; 30(3): 1-8.
Impact Factor: 1.396
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Combined Imaging With 18f-Fdg-Pet/Ct And 111in-Labeled Octreotide Spect For Evaluation Of Thymic Epithelial Tumors (246 visite)
De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S
Clin Nucl Med (ISSN: 1536-0229, 0363-3976, 0363-9762), 2013; 38(5): 354-358.
Impact Factor: 2.857
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives (66 visite)
Ciarmiello A, Fonti R, Giovacchini G, Del Vecchio S
Clinical And Translational Imaging, 2018; N/D: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy (248 visite)
Catalano L, Pace L, Califano C, Pinto AM, De Renzo A, Di Gennaro F, Del Vecchio S, Fonti R, Salvatore M, Rotoli B
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1998 Nov 15; 92(10): 119-124.
Impact Factor: 1.876
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis (252 visite)
Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B
Ann Hematol (ISSN: 0939-5555, 0939-5555linking), 2007 Jun; 86(6): 415-423.
Impact Factor: 2.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Follow-Up Of Solitary Plasmacytoma By 99mtc-Sestamibi Scintigraphy (248 visite)
Catalano L, Andretta C, Pace L, Del Vecchio S, Fonti R, Pollio G, Salvatore B, Esposito C, Salvatore M, Rotoli B
Haema (ISSN: 1108-2682), 2004; 7(3): 329-334.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Comparative distribution of urokinase receptor and urokinase in human breast cancer (196 visite)
Carriero MV, Stoppelli MP, Del Vecchio S, Franco P, Massa O, Fonti R, Salvatore M
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 1994; 35(0): N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Is 18F-FDG PET/CT acquisition from the upper thigh to the vertex of skull useful in oncological patients? (212 visite)
Capasso E, Salvatore B, De Falco T, Caprio MG, Mainolfi C, Storto G, Fonti R, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma (229 visite)
Camera L, Severino R, Faggiano A, Masone S, Mansueto G, Maurea S, Fonti R, Salvatore M
World J Radiol (ISSN: 1949-8470, 1949-8470electronic, 1949-8470linking), 2014 Oct 28; 6(10): 840-845.
Impact Factor: 0.567
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma [1] (multiple letters) (214 visite)
Blocklet D, Schoutens A, Kentos A, Feremans W, Fonti R, Del Vecchio S, Pace L
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001; 28(9): 1430-1432.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients [2] (198 visite)
Andretta C, Catalano L, Pace L, Fonti R, Annunziata G, Rotoli B
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2003 Jun; 44(6): 1081-1082.
Impact Factor: 1.163
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake in breast cancer cells during early phases of apoptosis induction with Staurosporine (234 visite)
Aloj L, Zannetti A, Caraco C, Fonti R, Del Vecchio S, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote